DrugPipeline.net has announced the addition of “Global Autologous Cell Therapy Market 2017 - 2021” research report to their website www.DrugPipeline.net

Bangalore, India -- (SBWire) -- 07/13/2017 --Autologous cell therapy belongs to the field of regenerative medicine and is based on biologic cell-based therapies to cure various diseases, including those of oncology, neurology, and dermatology, to name a few. Autologous cell therapy is one of the fastest growing segments of regenerative medicine and hence, is attracting significant research funds from various quarters.

Report forecast the global autologous cell therapy market to grow at a CAGR of 23.39% during the period 2017-2021.

The report covers the present scenario and the growth prospects of the global autologous cell therapy market for 2017-2021. To calculate the market size, the report considers the sales of autologous stem cell as well non-stem cell products.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Global Autologous Cell Therapy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Brainstorm Cell Therapeutics
- Holostem Advanced Therapies
- Osiris Therapeutics
- Valeant
- Vericel Corporation

Other prominent vendors
- AbbVie
- American CryoStem
- AM-Pharma
- Anterogen
- apceth Biopharma
- Astellas Pharma
- Athersys
- Baxter International
- Beike Biotechnology
- BIOTIME
- bluebird bio
- Bristol-Myers Squibb
- Brainxell
- Caladrius Biosciences
- Cellular Biomedicine Group
- Cellular Dynamics International (a subsidiary of Fujifilm)
- Cesca Therapeutics
- CHA Biotech
- Chugai Pharmaceutical
- Citospin
- Corestem
- Cytori Therapeutics
- Daiichi Sankyo
- Fujifilm
- Gamida Cell
- Global Stem Cells Group
- Grupo Ferrer Internacional
- GlaxoSmithKline
- Hemostemix
- Histocell
- International Stem Cell
- Ivy Institute of Stem Cells
- Japan Regenerative Medicine
- Kangstem Biotech
- Kiadis Pharma
- Laboratorios Salvat
- MEDIPOST
- Mesoblast
- Nuo Therapeutics
- Opsis Therapeutics
- Pharmicell
- Pluristem Therapeutics
- Promethera Biosciences
- Q Therapeutics
- ReNeuron
- RHEACELL
- Salus Medical Solutions
- Sangamo Therapeutics
- Shire
- Steminent Biotherapeutics
- Sumitomo Dainippon Pharma
- Taiwan Bio Therapeutics
- Takeda Pharmaceutical
- Teva Pharmaceutical Industries
- Thoratec Corporation
- TiGenix
- Translational Biosciences
- TWO CELLS
- U.S. Stem Cell
- ViaCyte
- VistaGen Therapeutics

Market driver
- Increasing demand for effective drugs for cardiac and degenerative disorders
- For a full, detailed list, view our report

Market challenge
- Critical ethical challenges with respect to stem cell research
- For a full, detailed list, view our report

Market trend
- Private funding will fuel market growth
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Spanning over 92 pages "Global Autologous Cell Therapy Market 2017 - 2021" report covers Executive summary, Scope of the report, Research Methodology, Introduction, Market landscape, Pipeline Landscape, Market segmentation by application, Market Segmentation by therapy, Geographical segmentation, Decision framework, Drivers and challenges, Market trends, Vendor landscape, Key vendor analysis, Appendix.

For more information Visit at: http://www.drugpipeline.net/technavio/global-autologous-cell-therapy-market-2017-2021

Find all Healthcare Reports at - http://www.drugpipeline.net/catalog/healthcare

Related Reports;

Global Mechanical Thrombectomy Devices Market 2017-2021 - Visit at - http://www.drugpipeline.net/technavio/global-mechanical-thrombectomy-devices-market-2017-2021

Global Blotting Systems Market 2017-2021 - Visit at - http://www.drugpipeline.net/technavio/global-blotting-systems-market-2017-2021

About DrugPipeline.net
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.